Development of the blood-CSF barrier

Area of Science:

• Neuroscience
• Developmental Biology
• Pediatrics

Background:

• The blood-cerebrospinal fluid (CSF) barrier is crucial for maintaining central nervous system homeostasis.
• Understanding its developmental trajectory is essential for diagnosing and managing neurological conditions in children.

Purpose of the Study:

• To investigate the developmental timeline of the blood-CSF barrier in healthy children from fetal stage to adolescence.
• To analyze protein and cell count changes in CSF and serum to assess barrier maturation and selectivity.

Main Methods:

• Collected CSF and serum samples from 185 healthy children (27 fetal weeks to 16 years).
• Measured total protein, individual protein concentrations (albumin, alpha 2-macroglobulin, IgG, IgM, IgA), and cell counts.
• Calculated serum:CSF ratios to evaluate barrier selectivity.

Main Results:

• Albumin, alpha 2-macroglobulin, and IgG were present in all CSF samples, with concentrations decreasing post-birth until age one.
• IgM was absent in CSF; IgA was found infrequently.
• Serum:CSF protein ratios increased, indicating reduced barrier selectivity during the first year.
• Maximal barrier maturation occurred around the third month of life, followed by a decline.
• Preterm infants' barrier status correlated with conceptional age, not birth timing.

Conclusions:

• The blood-CSF barrier undergoes significant development and maturation during early infancy.
• Barrier function shows dynamic changes in the first year, with reduced selectivity after initial maturation.
• Conceptional age is a key factor in blood-CSF barrier development for preterm infants.